Equities

Pak Fah Yeow International Ltd

Pak Fah Yeow International Ltd

Actions
  • Price (HKD)2.65
  • Today's Change-0.01 / -0.38%
  • Shares traded0.00
  • 1 Year change+86.62%
  • Beta--
Data delayed at least 15 minutes, as of May 23 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pak Fah Yeow International Ltd is an investment holding company principally engaged in the manufacture and sale of healthcare products. The Company operates through three segments. The Healthcare segment is engaged in the manufacture and sales of healthcare products under the brand names of Hoe Hin products. The Property Investment segment is engaged in the investment in commercial, office, industrial and residential properties. The Treasury Investment segment is engaged in the equity and debt securities, mutual funds and dual currency investments businesses.

  • Revenue in HKD (TTM)259.16m
  • Net income in HKD105.04m
  • Incorporated1991
  • Employees102.00
  • Location
    Pak Fah Yeow International Ltd11F, 200 Gloucester Road, Wanchai Hong KongHKG
  • Phone+852 28817713
  • Fax+852 25772895
  • Websitehttps://www.pakfahyeow.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.